PharmD Signal

Deep dives, evidence grades, and clinical tools, all in one place.

Esketamine Cuts Pediatric Emergence Delirium After Sevoflurane by Two-Thirds

esketamineS-ketamineNMDA receptor antagonistsevofluraneemergence deliriumemergence agitationpediatric anesthesiapostoperative painPONVmeta-analysistrial sequential analysis Perioperative / Anesthesia
Also in Pediatrics

Background Information

Esketamine reduces emergence delirium in children post-anesthesia.

Emergence delirium is a common postoperative issue in children after sevoflurane anesthesia, requiring effective preventive strategies. Esketamine reduced emergence delirium incidence (RR = 0.35, 95% CI: 0.26-0.48) and decreased pain scores with a slight prolongation in extubation time. This meta-analysis supports esketamine's use for preventing emergence delirium in pediatric anesthesia, though evidence certainty is moderate and further research is needed. Esketamine effectively reduces emergence delirium and pain in children under sevoflurane anesthesia.

📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.
Subscribe for $8/month → Read this one free →
Free account, no credit card. Includes 1 full deep analysis every month.

Authors: Lateiresh M, Louat A, Alwefati M, Altayf A, Legrand M, Cohen PD, Abdulwahed E, Kudchadkar SR, Elhadi M

Citation: Lateiresh M, Louat A, Alwefati M, et al. Effects of Esketamine on Emergence Delirium in Children Undergoing Sevoflurane Anesthesia: A Systematic Review, Meta-Analysis, and Trial Sequential Analysis. Paediatric anaesthesia. 2026;36(11):1361-1374. doi:10.1002/pan.70272

Article Links: PubMed · Journal / DOI · Free Full Text (PMC)

🎓
Reviewed by a licensed pharmacist
Every analysis is reviewed and approved by a licensed pharmacist before publication, ensuring clinical accuracy and relevance.
Accurate and up-to-date information is our highest priority.
If you spot an error, please suggest a correction. If there is a topic you want covered, tell us and we will look at it.
Thanks for the feedback!
🔒
Deep Analysis: Subscribers Only
Subscribers receive access to a complete clinical analysis, available online and as a downloadable PDF.
Executive Summary
Study Design
Patient Population
Primary Outcomes
Secondary Outcomes & Safety Profile
Pharmacist Implications
Clinical Pearls
Limitations
Controversies & Evidence Gaps
Cost & Logistics
Founding member rate
$8/month. Cancel anytime.

One subscription unlocks this analysis and every other one we publish, plus Practice Signals, PDF reports, and GRADE evidence grades.

Subscribe for $8/month → Read this one free →
Free account, no credit card. Includes 1 full deep analysis every month.
Or $79/year. Founding members keep this rate for as long as they stay subscribed. Cancel anytime from your Account page.